Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of Dexmedetomidine as an Opioid-Sparing Strategy in Thoracoscopic Surgery
NCT05431322Completed
- Sponsor
- Kaohsiung Veterans General Hospital
- Start
- Jun 2022
- Primary completion
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of dexmedetomidine in postoperative pain (2 arms), sponsored by Kaohsiung Veterans General Hospital. Primary endpoint: Perioperative dosage of fentanyl. Started Jun 2022; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05431322.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05431322.